RecruitingNot ApplicableNCT04730011

Short and Intensive Treatment of Children and Adolescents With Obsessive-Compulsive Disorder

Short and Intensive Treatment of Children and Adolescents With Obsessive-Compulsive Disorder - A Study to Evaluate the Effectiveness of an Intensive Treatment Week: "A Future Without Constraint"

Sponsor

Susanne Walitza

Enrollment

100 participants

Start Date

Jan 1, 2021

Study Type

INTERVENTIONAL

Conditions

Obsessive-Compulsive Disorder

Summary

Obsessive-compulsive disorders are very damaging illnesses; they can already appear in childhood and adolescence and become extremely chronic. With an average prevalence from 1-3%, they are among the most common psychiatric disorders in children and adolescents. 40% of diagnosed children and young adults display persistent and increasingly chronic symptoms and O-C disorders are highly complex syndromes with broadly varying manifestations. They arise from obsessive thoughts (ideas/thoughts or impulses, often senseless or tortured, that impose themselves or intrude) and obsessive behavior (ritualized patterns that must be frequently repeated).

Eligibility

Min Age: 8 YearsMax Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study tests a short, intensive treatment program for children and teenagers with obsessive-compulsive disorder (OCD). The program takes place over an intensive week of therapy, and researchers want to find out if this condensed format is effective. **You may be eligible if:** - You are between 8 and 18 years old - You have been diagnosed with OCD - You speak German well - Your IQ is at least 75 - You are able to attend and fully participate for at least four days of the intensive week - You and/or your legal guardian have given written consent **You may NOT be eligible if:** - You are unable to complete the full intensive treatment week Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.